These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 26460818)
1. Cathepsin K Deficiency Suppresses Disuse-Induced Bone Loss. Moriya S; Izu Y; Arayal S; Kawasaki M; Hata K; Pawaputanon Na Mahasarakhahm C; Izumi Y; Saftig P; Kaneko K; Noda M; Ezura Y J Cell Physiol; 2016 May; 231(5):1163-70. PubMed ID: 26460818 [TBL] [Abstract][Full Text] [Related]
2. Increased fracture callus mineralization and strength in cathepsin K knockout mice. Gentile MA; Soung do Y; Horrell C; Samadfam R; Drissi H; Duong LT Bone; 2014 Sep; 66():72-81. PubMed ID: 24928497 [TBL] [Abstract][Full Text] [Related]
3. Bone density, strength, and formation in adult cathepsin K (-/-) mice. Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279 [TBL] [Abstract][Full Text] [Related]
4. Elcatonin prevents bone loss caused by skeletal unloading by inhibiting preosteoclast fusion through the unloading-induced high expression of calcitonin receptors in bone marrow cells. Tsukamoto M; Menuki K; Murai T; Hatakeyama A; Takada S; Furukawa K; Sakai A Bone; 2016 Apr; 85():70-80. PubMed ID: 26851124 [TBL] [Abstract][Full Text] [Related]
5. Role of endoplasmic reticulum stress in disuse osteoporosis. Li J; Yang S; Li X; Liu D; Wang Z; Guo J; Tan N; Gao Z; Zhao X; Zhang J; Gou F; Yokota H; Zhang P Bone; 2017 Apr; 97():2-14. PubMed ID: 27989543 [TBL] [Abstract][Full Text] [Related]
6. MURF1 deficiency suppresses unloading-induced effects on osteoblasts and osteoclasts to lead to bone loss. Kondo H; Ezura Y; Nakamoto T; Hayata T; Notomi T; Sorimachi H; Takeda S; Noda M J Cell Biochem; 2011 Dec; 112(12):3525-30. PubMed ID: 21866567 [TBL] [Abstract][Full Text] [Related]
7. The effects of the cathepsin K inhibitor odanacatib on osteoclastic bone resorption and vesicular trafficking. Leung P; Pickarski M; Zhuo Y; Masarachia PJ; Duong LT Bone; 2011 Oct; 49(4):623-35. PubMed ID: 21718816 [TBL] [Abstract][Full Text] [Related]
8. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014 [TBL] [Abstract][Full Text] [Related]
10. Altered hematopoietic stem cell and osteoclast precursor frequency in cathepsin K null mice. Jacome-Galarza C; Soung do Y; Adapala NS; Pickarski M; Sanjay A; Duong LT; Lorenzo JA; Drissi H J Cell Biochem; 2014 Aug; 115(8):1449-57. PubMed ID: 24590570 [TBL] [Abstract][Full Text] [Related]
11. Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass. Li CY; Jepsen KJ; Majeska RJ; Zhang J; Ni R; Gelb BD; Schaffler MB J Bone Miner Res; 2006 Jun; 21(6):865-75. PubMed ID: 16753017 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of adiponectin protects against ovariectomy-induced osteoporosis in mice. Wang F; Wang PX; Wu XL; Dang SY; Chen Y; Ni YY; Gao LH; Lu SY; Kuang Y; Huang L; Fei J; Wang ZG; Pang XF PLoS One; 2013; 8(7):e68497. PubMed ID: 23844209 [TBL] [Abstract][Full Text] [Related]
13. Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice. Sakai A; Sakata T; Ikeda S; Uchida S; Okazaki R; Norimura T; Hori M; Nakamura T J Bone Miner Res; 1999 Oct; 14(10):1691-9. PubMed ID: 10491216 [TBL] [Abstract][Full Text] [Related]
15. Azanitrile Cathepsin K Inhibitors: Effects on Cell Toxicity, Osteoblast-Induced Mineralization and Osteoclast-Mediated Bone Resorption. Ren ZY; Machuca-Gayet I; Domenget C; Buchet R; Wu Y; Jurdic P; Mebarek S PLoS One; 2015; 10(7):e0132513. PubMed ID: 26168340 [TBL] [Abstract][Full Text] [Related]
16. Induction of Lrp5 HBM-causing mutations in Cathepsin-K expressing cells alters bone metabolism. Kang KS; Hong JM; Horan DJ; Lim KE; Bullock WA; Bruzzaniti A; Hann S; Warman ML; Robling AG Bone; 2019 Mar; 120():166-175. PubMed ID: 30409757 [TBL] [Abstract][Full Text] [Related]
17. Effects of pharmacological inhibition of cathepsin K on fracture repair in mice. Soung do Y; Gentile MA; Duong LT; Drissi H Bone; 2013 Jul; 55(1):248-55. PubMed ID: 23486186 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological inhibition of cathepsin K: A promising novel approach for postmenopausal osteoporosis therapy. Mukherjee K; Chattopadhyay N Biochem Pharmacol; 2016 Oct; 117():10-9. PubMed ID: 27106079 [TBL] [Abstract][Full Text] [Related]
19. Effect of vitamin K2 on cortical and cancellous bones in orchidectomized and/or sciatic neurectomized rats. Iwamoto J; Yeh JK; Takeda T J Bone Miner Res; 2003 Apr; 18(4):776-83. PubMed ID: 12674339 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of cathepsin K promotes osseointegration of titanium implants in ovariectomised rats. Yi C; Hao KY; Ma T; Lin Y; Ge XY; Zhang Y Sci Rep; 2017 Mar; 7():44682. PubMed ID: 28304382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]